(603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Key Operating Data for Q3 2026
Filed with SSE · Stock code 603079 · · 2 pages · Chinese
Summary by 6ix AI
The announcement includes details on production, sales, and revenue for its main products, including vitamins and biological preservatives. It also discusses price changes for major products and raw materials during the reporting period. The data provided is unaudited and aims to inform investors about the company's operational performance.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/603079zhejiang-shengda-bio-pharm-co-ltdannouncement-on-key-operating-data-for-q3-2026
Zhejiang Shengda Bio-Pharm Co., Ltd. on 6ix
Story so far
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Repurchasing Shares
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Using Idle Raised Funds for Cash Management
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
Earlier from Zhejiang Shengda Bio-Pharm
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Repurchasing Shares
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Using Idle Raised Funds for Cash Management
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
- Announcement on Progress in Opening Dedicated Settlement Account for Cash Management Products Purchased with Raised Funds and Using Idle Raised Funds for Cash Management
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
Follow Zhejiang Shengda Bio-Pharm into a list and get an email when it puts out news.
Follow Zhejiang Shengda Bio-Pharm